—
C+
C+ The full Closelook — membership. Open the C+ overview

AbbVie Inc (ABBV) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — AbbVie Inc

ABBV in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
AbbVie is a biopharmaceutical company that researches, makes and sells medicines and treatments worldwide. Its range covers Skyrizi and Rinvoq for immune disease, Imbruvica and Venclexta for blood cancers, Elahere and Epkinly for other cancers, and Botox and Juvederm for aesthetic use. It also sells eye care, digestive and migraine products. The company is based in North Chicago, Illinois.
Where it sits in the stack
AbbVie carries no Rubin or Halo seat, so it sits outside the AI build-out layers the diary tracks. In our universe it belongs to the Healthcare sector, within the drug manufacturers industry group.
Who it is priced against
Closelook has not set a peer group for AbbVie. The market commonly compares it with other large pharmaceutical makers, Pfizer among them, on pipeline breadth and franchise mix.
Why Closelook tracks it
AbbVie holds a seat in the S&P 500 among our indices but carries no Rubin or Halo listing and no Closelook score yet. It has not appeared in the diary's quoted editions.
What the diary watches
The diary watches how AbbVie's newer immunology and oncology drugs perform against its older franchises, and whether analyst price targets keep moving away from the current level.

AbbVie Inc (ABBV) trades on US exchanges.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: ABBV news on the tape · index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for ABBV, from the same nightly bakes the boards use. Research diary readings, not advice.

The Street on this name 1 analyst action on the wire · latest: price target by Piper Sandler, 2026-08-20

The Street on this name

Analyst actions and the latest print for ABBV from the Closelook wires — third-party opinions on the record, not our readings.

  • Price target Piper Sandler — target 303 from 298 Target raised to $303 from $298 (+13.9% to spot) 2026-08-20

1 action on the analyst wire since 2026-08-13: 1 target change. Analyst wire → · Earnings wire →

Who it is priced against Drug Manufacturers - General · US · 8 names with week and year-to-date

Peer group

Drug Manufacturers - General · US

This name carries no Closelook score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against ABBV on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is AbbVie Inc (ABBV)?

AbbVie Inc trades as ABBV on the US exchange (US) in the Closelook research universe, as of the registry build of 2026-09-18.

Is ABBV in a Closelook index?

Not currently — AbbVie Inc is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-18.

Where does ABBV trade against its moving averages?

Uptrend stack intact: Trades +3.6% vs the 50-day and +15.7% vs the 200-day average, 1.3% below the 52-week high and +38.4% off the 52-week low; a golden cross printed 52 sessions ago. Computed from daily closes. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does AbbVie Inc do?

AbbVie is a biopharmaceutical company that researches, makes and sells medicines and treatments worldwide. Its range covers Skyrizi and Rinvoq for immune disease, Imbruvica and Venclexta for blood cancers, Elahere and Epkinly for other cancers, and Botox and Juvederm for aesthetic use. It also sells eye care, digestive and migraine products. Closelook has not set a peer group for AbbVie. The market commonly compares it with other large pharmaceutical makers, Pfizer among them, on pipeline breadth and franchise mix.

Where does AbbVie Inc sit in the AI build-out?

AbbVie carries no Rubin or Halo seat, so it sits outside the AI build-out layers the diary tracks. In our universe it belongs to the Healthcare sector, within the drug manufacturers industry group. AbbVie holds a seat in the S&P 500 among our indices but carries no Rubin or Halo listing and no Closelook score yet. It has not appeared in the diary's quoted editions.

What has Wall Street done on AbbVie Inc recently?

The most recent analyst action on AbbVie Inc on the Closelook wire is a price target by Piper Sandler on 2026-08-20 (target 303 from 298). 1 action on the analyst wire since 2026-08-13: 1 target change. Analyst actions are third-party opinions recorded by the wire, not Closelook readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for ABBV, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe

then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.